DECOY THERAPEUTICS INC (DCOY) Forecast, Price Target & Analyst Ratings
NASDAQ:DCOY • US79400X5032
0.5825 USD
-0.07 (-11.34%)
At close: Mar 5, 2026
0.5775 USD
-0.01 (-0.86%)
After Hours: 3/5/2026, 5:43:56 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DECOY THERAPEUTICS INC (DCOY).
Forecast Snapshot
Consensus Price Target
$2.55
+ 337.77% Upside
Next Earnings Forecast
Release DateMar 19, 2026
PeriodQ4 / 2025
EPS Estimate-$6.01
Revenue Estimate
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.55
Upside
+ 337.77%
From current price of $0.58 to mean target of $2.55, Based on 6 analyst forecasts
Low
$2.53
Median
$2.55
High
$2.63
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
6 analysts have analysed DCOY and the average price target is 2.55 USD. This implies a price increase of 337.77% is expected in the next year compared to the current price of 0.5825.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
DCOY was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about DCOY.
In the previous month the buy percentage consensus was at a similar level.
DCOY was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-23 | Ladenburg Thalmann | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 19, 2026
PeriodQ4 / 2025
EPS Estimate-$6.01
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q12.22%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
DCOY is expected to report earnings on 3/19/2026. The consensus EPS estimate for the next earnings is -6.01 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.465M 313.45% | 5.233M 51.03% | 1.84M -64.84% | -100.00% | 12.113M | ||||
| EBITDA YoY % growth | -8.138M 60.27% | -7.768M 4.54% | -12.794M -64.69% | N/A -79.53% | N/A 43.90% | N/A 55.53% | N/A | N/A | |
| EBIT YoY % growth | -8.265M 60.09% | -7.786M 5.79% | -12.813M -64.55% | -22.734M -79.31% | -18.21M 43.87% | -6.242M 55.53% | -6.25M -8.99% | N/A | |
| Operating Margin | -238.52% | -148.79% | -696.28% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -1,650.00 72.77% | -900.00 45.45% | -911.27 -44.00% | -5.25 99.59% | -4.12 21.55% | -9.35 -126.98% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -6.01 12.22% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
DECOY THERAPEUTICS INC / DCOY Forecast FAQ
Can you provide the average price target for DECOY THERAPEUTICS INC stock?
6 analysts have analysed DCOY and the average price target is 2.55 USD. This implies a price increase of 337.77% is expected in the next year compared to the current price of 0.5825.
Can you provide the upcoming earnings date for DECOY THERAPEUTICS INC?
DECOY THERAPEUTICS INC (DCOY) will report earnings on 2026-03-19, after the market close.
What are the consensus estimates for DECOY THERAPEUTICS INC (DCOY) next earnings?
The consensus EPS estimate for the next earnings of DECOY THERAPEUTICS INC (DCOY) is -6.01 USD and the consensus revenue estimate is 0 USD.
Can you provide the consensus rating for DECOY THERAPEUTICS INC stock?
The consensus rating for DECOY THERAPEUTICS INC (DCOY) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.